Arab Journal of Gastroenterology
Volume 11, Issue 2 , Pages 105-107 , June 2010

Prevalence of hepatitis B and C viral markers in chronic liver disease patients: A single center experience from Yemen

Received 11 November 2009 ,Accepted 9 April 2010.

References 

  1. EASL International consensus conference on hepatitis B 13–14 September, 2002 Geneva, Switzerland. Consensus statement (Short version). J Hepatol 2003;38(4):533–40.
  2. Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol. 2003;39(Suppl. 1):S64–S69
  3. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5(9):558–567
  4. Shim J, Kim BH, Kim NH, et al. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area. J Gastroenterol Hepatol. 2005;20(5):746–751
  5. Berger A, Doerr HW, Rabenau HF, et al. High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen. Intervirology. 2000;43(2):71–76
  6. Bukhtiari N, Hussain T, Iqbal M, et al. Hepatitis B and C single and co-infection in chronic liver disease and their effect on the disease pattern. J Pak Med Assoc. 2003;53(4):136–140
  7. Xess A, Kumar M, Minz S, et al. Prevalence of hepatitis B and hepatitis C virus coinfection in chronic liver disease. Indian J Pathol Microbiol. 2001;44(3):253–255
  8. Kazemi Shirazi L, Petermann D, Muller C. Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C. J Hepatol. 2000;33(5):785–790
  9. Fukuda R, Ishimura N, Niigaki M, et al. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol. 1999;58(3):201–207
  10. Lee DS, Huh K, Lee EH, et al. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area. J Gastroenterol Hepatol. 1997;12(12):855–861
  11. Marusawa H, Osaki Y, Kimura T, et al. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan. Gut. 1999;45(2):284–288
  12. Uetake S, Yamauchi M, Itoh S, et al. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Alcohol Clin Exp Res. 2003;27(Suppl. 8):47S–51S
  13. Sood A, Sidhu SS, Midha V, et al. High seroprevalence of hepatitis C virus and dual infection (hepatitis B and C virus) in non-alcoholic chronic liver disease in North India. J Assoc Physicians India. 1999;47(2):205–208
  14. Chakravarti A, Verma V, Kumaria R, et al. Anti-HCV seropositivity among multiple transfused patients with beta thalassaemia. J Indian Med Assoc. 2005;103(2):64–66
  15. Weir RP, Brunton CR, Blakely TA. Chronic liver disease mortality attributable to hepatitis B and C in New Zealand. J Gastroenterol Hepatol. 2002;17(5):582–588
  16. Berry N, Chakravarti A, Kar P, et al. Association of hepatitis C virus & hepatitis B virus in chronic liver disease. Indian J Med Res. 1998;108:255–259
  17. Fan CL, Wei L, Jiang D, et al. Clinical and virological course of dual infection by hepatitis B and C viruses in China. Zhonghua Yi Xue Za Zhi. 2003;83(14):1214–1218
  18. Fan CL, Wei L, Jiang D, et al. Spontaneous viral clearance after 6–21years of hepatitis B and C viruses coinfection in high HBV endemic area. World J Gastroenterol. 2003;9(9):2012–2016

PII: S1687-1979(10)00049-3

doi: 10.1016/j.ajg.2010.04.006

Arab Journal of Gastroenterology
Volume 11, Issue 2 , Pages 105-107 , June 2010

Article Tools